XOMA Corporation (XOMA)
20.00
-0.97 (-4.63%)
At close: Mar 28, 2025, 3:59 PM
Company Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific.
The company engages in helping biotech companies for enhancing human health.
It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies.
The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners.
It has a portfolio with approximately 70 assets.
XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
XOMA Corporation
| Country | United States |
| IPO Date | Jun 6, 1986 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 13 |
| CEO | Owen P. Hughes Jr. |
Contact Details
Address: 2200 Powell Street EmeryVille, California United States | |
| Website | https://www.xoma.com |
Stock Details
| Ticker Symbol | XOMA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000791908 |
| CUSIP Number | 98419J206 |
| ISIN Number | US98419J2069 |
| Employer ID | 52-2154066 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Owen P. Hughes Jr. | Chief Executive Officer & Director |
| Thomas M. Burns | Senior Vice President of Finance & Chief Financial Officer |
| Brad Sitko | Chief Investment Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 25, 2025 | 4 | Filing |
| Mar 17, 2025 | 10-K | Annual Report |
| Mar 17, 2025 | 8-K | Current Report |
| Feb 11, 2025 | 8-K/A | [Amend] Current Report |
| Jan 28, 2025 | 4 | Filing |
| Jan 28, 2025 | SCHEDULE 13D/A | [Amend] Filing |
| Jan 10, 2025 | 4 | Filing |
| Jan 03, 2025 | 4 | Filing |
| Dec 02, 2024 | 8-K | Current Report |
| Nov 13, 2024 | 4 | Filing |